725 / 1631
11.7
18.5
9.0
9.0
10.1
9.5
58.0
50.8
11.2
12.2
0
20
40
60
80
100
G-B
n=188
B
n=189
Patients (%)
GADOLIN: Response to therapy
69.2
63.0
* Patients ongoing in induction therapy are excluded from analysis. Patients with end of induction response assessment performed >60 days after last induction dose shown as missing.
** Best overall response excludes ongoing patients who have not yet reached the first response assessment.
IRF, independent radiology facility
End-of-induction response
(IRF)
5.7
7.6
4.7
4.1
10.9
11.7
62.0
59.4
16.7
17.3
0
20
40
60
80
100
G-B
n=192**
B
n=197**
Patients (%)
CR
PR
SD
PD
NE/missing
78.7
76.7
Best overall response to 12 months (IRF)